POTASSIUM CHLORIDE

Adults and Children The volume and rate of infusion will depend upon the requirements of the individual patient and the judgement of the physician. The rate of infusion should not exceed 10-20 mmols of potassium per hour. The total daily dosage of potassium should not exceed 200 mmols of potassium.

Children Correspondingly reduced volumes and rates of infusion may be required. Elderly The volume and rate of infusion may be necessary to avoid circulatory overload, particularly in patients with cardiac or renal insufficiency. Method of administration For Solution for Infusion

Adverse effects are usually due to hyperkalaemia and include listlessness, mental confusion, parasthesiae, weakness, hypertension, arrhythmias and sometimes cardiac arrest. Thrombosis of the selected vein may occasionally occur.

Reporting of side effects:

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. uk/yellow card or search for MHRA Yellow card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

Caution should be exercised in the volume and rate of infusion since fluid overload and hyperkalaemia may compromise cardiac function. Before administering potassium by the intravenous route a non-potassium containing hydrating solution should be administered to ensure adequate renal function.

The label states:

Do not use unless the solution is clear and free from particles. Rapid infusion may be harmful. Contains 20 mmol Potassium (500 ml) Contains 40 mmol Potassium (1000 ml)

Addison's disease, adrenal insufficiency, acute or chronic renal disease, oliguria, anuria and patients with hyperkalaemia. The intravenous infusion of glucose solutions may also be hazardous in patients with impaired hepatic function.